SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-17-033835
Filing Date
2017-06-23
Accepted
2017-06-23 16:09:10
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A v469302_20fa.htm 20-F/A 43349
2 EXHIBIT 12.1 v469302_ex12-1.htm EX-12.1 4413
3 EXHIBIT 12.2 v469302_ex12-2.htm EX-12.2 4349
4 EXHIBIT 15.1 v469302_ex15-1.htm EX-15.1 4038
  Complete submission text file 0001144204-17-033835.txt   57154
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-36345 | Film No.: 17927668
SIC: 2834 Pharmaceutical Preparations